
10,000+ employees
Founded 2010
đ§Ź Biotechnology
đĽ Healthcare
đ Pharmaceuticals
Biotechnology ⢠Healthcare ⢠Pharmaceuticals
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting the development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.
đ October 8
đ United States, Switzerland â Remote
đľ $153.1k - $203.1k / year
â° Full Time
đ Senior
đ Director
đť Ghost score 1%
Improve your chances of getting an interview by checking your resume score before you apply.

10,000+ employees
Founded 2010
đ§Ź Biotechnology
đĽ Healthcare
đ Pharmaceuticals
Biotechnology ⢠Healthcare ⢠Pharmaceuticals
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting the development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.
⢠Drive global value, access, pricing, and reimbursement launch-readiness for an assigned asset across geographies ⢠Translate pivotal evidence and the competitive landscape into differentiated global access and pricing tactics ⢠Develop country-ready toolkits enabling local affiliates to secure timely reimbursement and optimal patient access ⢠Coordinate with Hematology portfolio leads whose assets share similar indications ⢠Collaborate with HEOR, Medical, Commercial, Clinical Development, Regulatory, Pricing, Medical Affairs, and affiliate teams ⢠Develop and help lead global market access and reimbursement strategies across lead and future pipeline indications ⢠Provide GVAP input to lifecycle planning, indication sequencing, evidence prioritization, governance, and oversight ⢠Translate payer insights into recommendations for clinical development, evidence generation, pricing, access strategy, and commercialization planning ⢠Integrate access and payer requirements into development processes, including trial design, endpoints, and evidence generation ⢠Build global value dossiers, budget-impact and cost-effectiveness frameworks, and payer communication materials ⢠Support EU Joint Clinical Assessment strategy and dossier development ⢠Track access milestones, evidence needs, and deliverables against launch plans; flag risks and dependencies ⢠Serve as day-to-day contact for regional and affiliate teams on access and pricing deliverables ⢠Train teams on access toolkits and share materials ⢠Monitor competitive, pricing, HTA, and policy landscapes, including BTK-class dynamics and EU HTA/JCA developments ⢠Report affiliate and payer insights to the Director
⢠Undergraduate science degree required ⢠Bachelor's degree in life sciences, health economics, pharmacy, health policy, business, or a related field ⢠8+ years of biopharmaceutical experience, with a substantial portion in global, regional, or country value, access, pricing, and reimbursement roles ⢠Demonstrated expertise in HTA processes and payer systems across key markets, including G-BA/IQWiG, NICE, and HAS ⢠Knowledge of the US payer environment; IRA/MFN awareness is a plus ⢠Experience building global value dossiers, HTA/EU HTA JCA submission content, and payer value evidence in partnership with HEOR ⢠Working knowledge of global or major-market pricing strategy, IRP/reference-pricing management, and price/revenue scenario modelling for specialty or oncology/hematology products ⢠Strong understanding of pivotal-trial evidence interpretation and comparator/competitive assessment in oncology or hematology ⢠Proven ability to lead cross-functional and cross-regional initiatives and influence without direct authority in a matrixed, global organisation ⢠Excellent written and verbal communication skills in English ⢠International travel expected ⢠Advanced degree (MSc, MPH, PharmD, PhD, or MBA) strongly preferred ⢠In-country, regional, or affiliate market access, pricing, reimbursement, or HTA experience preferred ⢠Launch experience in oncology/hematology, ideally including EU JCA launches, preferred ⢠HEOR fluency in budget-impact and cost-effectiveness modelling preferred
⢠Annual bonus plan for Non-Commercial roles ⢠Incentive compensation plan for Commercial roles ⢠Discretionary equity awards ⢠Employee Stock Purchase Plan ⢠Medical insurance ⢠Dental insurance ⢠Vision insurance ⢠401(k) ⢠FSA/HSA ⢠Life Insurance ⢠Paid Time Off ⢠Wellness benefits ⢠International travel support
Apply Nowđ October 8
Senior Director/VP leading JAGGAERâs SaaS partner ecosystem across North America. Driving alliances, co-selling, enablement, and measurable procurement technology revenue growth.
đşđ¸ United States â Remote
đ° Private Equity Round on 2019-07
â° Full Time
đ Senior
đ Director
đŚ H1B Visa Sponsor
đ October 8
Breast oncology lifecycle leader shaping commercial strategy for Nateraâs cfDNA diagnostics. Driving evidence planning, market access, KOL engagement, and Signatera adoption.
đşđ¸ United States â Remote
đľ $153.9k - $233.3k / year
â° Full Time
đ Senior
đ Director
đŚ H1B Visa Sponsor
đ October 8
1001 - 5000
đ Pharmaceuticals
đĽ Healthcare
đ§Ź Biotechnology
Omnichannel therapeutic area leader advancing data-driven customer engagement for Otsuka Pharmaceuticals. Connecting brand strategy, analytics, CRM, and orchestration across therapeutic areas.
đ October 8
Senior Director leading Diversifiedâs global treasury function for a PE-backed portfolio. Overseeing liquidity, banking, debt, risk, controls, and capital transactions.
đşđ¸ United States â Remote
đ° Private Equity Round - Diversified Systems on 2022-12
â° Full Time
đ Senior
đ Director
đ October 8
Senior Director leading ICU Medicalâs global logistics organization for IV therapy and critical care products. Driving transportation, warehousing, distribution performance, compliance, and cost improvement.